OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
/PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene...